The timing of liver transplantation in primary biliary cirrhosis
- PMID: 10976021
- DOI: 10.1053/bega.2000.0110
The timing of liver transplantation in primary biliary cirrhosis
Abstract
Primary biliary cirrhosis, the most common chronic cholestatic liver disease in adults, usually progresses to cirrhosis and its complications. Ursodeoxycholic acid therapy delays disease progression, but most patients will ultimately succumb. Liver transplantation is now accepted as the standard treatment for end-stage PBC. Development of major complications of portal hypertension and liver failure, poor quality of life and short survival without transplantation are the major indications for this surgical intervention in patients with primary biliary cirrhosis. Resource use is another key variable to be considered in the timing of liver transplantation. Prognostic models have been developed to predict survival and resource utilization with and without liver transplantation. Prognostic models aid the clinician in the selection and timing of liver transplantation in the patient with primary biliary cirrhosis.
Copyright 2000 Harcourt Publishers Ltd.
Similar articles
-
Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?Liver Transpl Surg. 1998 Sep;4(5 Suppl 1):S9-17. Liver Transpl Surg. 1998. PMID: 9742489 Review.
-
[Treatment of cholestatic liver diseases with ursodeoxycholic acid].Tidsskr Nor Laegeforen. 1997 Sep 30;117(23):3370-3. Tidsskr Nor Laegeforen. 1997. PMID: 9411890 Review. Norwegian.
-
Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.Liver Transpl. 2007 Sep;13(9):1236-45. doi: 10.1002/lt.21124. Liver Transpl. 2007. PMID: 17763401
-
Pretransplant ursodeoxycholic acid therapy and liver transplantation in patients with primary biliary cirrhosis: win, win, win?Liver Transpl Surg. 1999 Jul;5(4):334-7. doi: 10.1002/lt.500050403. Liver Transpl Surg. 1999. PMID: 10388507 No abstract available.
-
Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.Aliment Pharmacol Ther. 2005 Feb 1;21(3):217-26. doi: 10.1111/j.1365-2036.2005.02318.x. Aliment Pharmacol Ther. 2005. PMID: 15691295
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical